Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
26 May 2020 - 12 June 2020
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2020

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
Deviations:
no
GLP compliance:
yes (incl. QA statement)

Test material

Constituent 1
Chemical structure
Reference substance name:
Boronic acid, [6-(benzoylmethylamino)-5-methyl-3-pyridinyl]-
Cas Number:
446299-81-6
Molecular formula:
C14H15BN2O3
IUPAC Name:
Boronic acid, [6-(benzoylmethylamino)-5-methyl-3-pyridinyl]-
Test material form:
solid: particulate/powder

In vitro test system

Test system:
human skin model
Remarks:
(EpiDermTM model)
Source species:
human
Cell type:
non-transformed keratinocytes
Justification for test system used:
The EpiDermTM model has been validated for irritation testing and its use is recommended by the relevant OECD guideline for irritation testing (OECD No. 439); therefore, it was considered to be suitable for this study.
Vehicle:
unchanged (no vehicle)
Details on test system:
RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: EpiDermTM model
- Tissue batch number(s): 30872.
- Production date: N/A
- Shipping date: 09.06.2020
- Delivery date: 09.06.2020
- Date of initiation of testing: 10.06.2020

TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: 35 minutes at 37ºC and 25 minutes at room temperature.
- Temperature of post-treatment incubation (if applicable): 37ºC

REMOVAL OF TEST MATERIAL AND CONTROLS
-Volume and number of washing steps: 15 x 1 mL of DPBS
- Observable damage in the tissue due to washing: no
- Modifications to validated SOP: no

MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: 300 µL of a MTT solution at 1.0 mg/mL
- Incubation time: 3 hours at 37ºC, 5% CO2
- Spectrophotometer: ELx800 absorbance microplate reader (BioTek)
- Wavelength: 570 nm

FUNCTIONAL MODEL CONDITIONS WITH REFERENCE TO HISTORICAL DATA
- Viability: O.D. = 1.971 (Acceptance criterion: 1.0-3.0). Historical negative control mean OD range = 0.530-1.211 (OD measured after 1:2 dilution in isopropanol; acceptability criteria should be in the range ≥ 0.4 and ≤1.4)
- Barrier function: 6.35 h (Acceptance criterion: 4.77h < ET50< 8.72h)
- Morphology: Tissue viability and barrier function test are within the acceptable ranges and indicate appropriate formation of the epidermal barrier, the presence of a functinal stratum corneum, a viable basal cell layer and intermediate spinous and granular layers.
- Contamination: No.

NUMBER OF REPLICATE TISSUES: 3

CONTROL TISSUES USED IN CASE OF MTT DIRECT INTERFERENCE: there is no direct interaction between the test item and MTT.

NUMBER OF INDEPENDENT TEST SEQUENCES / EXPERIMENTS TO DERIVE FINAL PREDICTION: 1

PREDICTION MODEL / DECISION CRITERIA
- The test item is considered as non-irritant to skin if the mean percent viability after 60 minutes exposure and 42 hours of post-treatment incubation is > 50%.
- The test item is identified as requiring classification and labelling according to UN GHS (Category 2) if the mean percent tissue viability after 60 minutes exposure and 42 hours of post-treatment incubation is ≤ 50% and the result of a skin corrosion test is “non corrosive”.
- The test item is identified as requiring classification and labelling according to UN GHS (Category 2 or Category 1) if the mean percent tissue viability after 60 minutes exposure and 42 hours of post-treatment incubation is ≤ 50% and in absence of information on a skin corrosion test.




Control samples:
yes, concurrent negative control
yes, concurrent positive control
Amount/concentration applied:
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 25 mg (39 mg/cm2)

NEGATIVE CONTROL
- Amount(s) applied (volume or weight): 30 µL

POSITIVE CONTROL
- Amount(s) applied (volume or weight): 30 µL
- Concentration (if solution): 5% SDS
Duration of treatment / exposure:
35 min at 37ºC and 25 min at room temperature.
Duration of post-treatment incubation (if applicable):
43 hours and 45 minutes
Number of replicates:
3

Results and discussion

In vitro

Results
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
mean
Value:
96
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Remarks:
(distilled water)
Positive controls validity:
valid
Remarks:
3.6% viability (5% SDS)
Other effects / acceptance of results:
- OTHER EFFECTS:
- Visible damage on test system: no

DEMONSTRATION OF TECHNICAL PROFICIENCY: yes. A full demonstration of proficiency was performed for the EpiSkin model, plus a reduced validation with the EpiDerm model, having into account that both models are very similar. Adequate results were obtained for the evaluated chemicals.

ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: yes, mean OD = 0.957 (OD measured after 1:2 dilution in isopropanol; acceptability criteria should be in the range ≥ 0.4 and ≤1.4).
- Acceptance criteria met for positive control: yes, mean viability = 3.6% (acceptability criteria should be < 20%).
- Acceptance criteria met for variability between replicate measurements: yes. SD of negative, positive and test item replicates were 12.6, 0.3 and 1.8% respectively (acceptablility criteria, SD ≤ 18%).

Any other information on results incl. tables

Table 1. Table of results

Well ID OD Mean OD /
disc (#)
Mean OD /
product
Viability
%
Mean viability
%
SD
viability
Conclusion
Negative
control
SPL 1 0.729 0.818 0.957 85.5 100.0 12.6  
0.925
0.802
SPL 2 1.012 1.029 107.6
1.031
1.045
SPL 3 0.964 1.023 106.9
1.049
1,057
Positive
control
SPL 4 0.032 0.032 0.035 3.3 3.6 0.3 Irritant
0.033
0.031
SPL 5 0.030 0.034 3.6
0.035
0.039
SPL 6 0.037 0.038 4.0
0.042
0.036
Test item
PH-20/0316
SPL 13 0.876 0.907 0.918 94.8 96.0 1.8 Non irritant
0.956
0.890
SPL 14 0.914 0.938 98.0
0.937
0.964
SPL 15 0.902 0.910 95.1
0.911
0.917

# mean of 3 values (triplicate of the same extract).

Applicant's summary and conclusion

Interpretation of results:
other: Not classified (CLP Regulation EC no. 1272/2008)
Conclusions:
The test substance can be considered as not irritant to skin as the mean percent viability of the treated tissues was found 96.0% in the in vitro RhE test.
Executive summary:

An in vitro skin irritation test was conducted for the test item in a reconstructed human epidermis model ( EpiDerm™) according to OECD TG 439 (GLP study). Three epidermis units, previously moistened with 25 μL of distilled water, were treated with 25 mg test item for 35 minutes at 37ºC, 5% CO2 then during 25 minutes at room temperature. Exposure of the test item was terminated by rinsing with 15 x 1 mL of DPBS. The epidermis units were then incubated for a 24 hours post-treatment incubation period in 6 wells culture plate filled with 900 μL of fresh medium at 37ºC, 5% CO2, then placed into 900 μL of fresh new assay medium during 19 hours and 45 minutes, at 37ºC, 5% CO2. The viability of each disk was assessed by incubating the tissues with MTT, extracting the precipitated formazan crystals using isopropanol during 2 hours under gentle agitation in the dark, and measuring the concentration of formazan by determining the OD at 570 nm, just after dilution of the extracts 1:2 in isopropanol. Under the test conditions, the mean percent viability of the treated tissues was 96.0%, versus 3.6% in the positive control (5% Sodium Dodecyl Sulfate). Therefore, the test item is considered as not irritant to the skin.